International Journal of Medical Advances and Discoveries

International Scholars Journal of Medical Advances and Discoveries | Vol. 16, No. 3, March 2025 | pp. 9–16

DOI: 10.46882/2025/IJMAD/000102

Clinical Review

Title: Mechanisms of Insulin Resistance in Gestational Diabetes Mellitus and Therapeutic Implications for Fetal Outcomes

Names of Authors: G. H. Patel¹, I. J. Van Der Merwe²

Authors’ Affiliations: ¹Division of Endocrinology, Metro Health Sciences Center, Mumbai, India; ²Department of Obstetrics and Gynecology, Stellenbosch University, Cape Town, South Africa

Abstract: Gestational diabetes mellitus (GDM) represents a complex metabolic disturbance characterized by progressive maternal insulin resistance coupled with inadequate pancreatic beta-cell compensation during pregnancy. This comprehensive review synthesizes recent insights into the molecular signaling pathways—specifically alterations in the IRS-1/PI3K/AKT cascade—triggered by placental hormones, systemic low-grade inflammation, and elevated circulating free fatty acids (mean increase of 35% compared to normoglycemic pregnancies). We examine how maternal hyperglycemia drives fetal hyperinsulinemia, leading to macrosomia, neonatal hypoglycemia, and long-term metabolic risks for the offspring. The therapeutic efficacy of lifestyle modifications, traditional insulin regimens, and emerging second-line oral hypoglycemic agents such as metformin and glyburide is critically appraised. Particular emphasis is placed on maintaining target fasting blood glucose levels below 5.3 mmol/L and 1-hour postprandial levels below 7.8 mmol/L to mitigate perinatal morbidity. Furthermore, we explore the potential of novel biomarkers, including adiponectin and microRNA profiles (e.g., miR-16 and miR-20a), for early first-trimester risk stratification before standard 24-28 week oral glucose tolerance testing occurs. Integrating these pathogenetic mechanisms with individualized glycemic control strategies offers clinicians an optimized framework for reducing both immediate obstetric complications and the transgenerational cycle of metabolic syndrome. Continued research into targeted placental drug delivery systems remains paramount for minimizing transplacental transfer of pharmacological agents while preserving maternal metabolic equilibrium throughout gestation.

Keywords: Gestational diabetes; Insulin resistance; Fetal macrosomia; Placental signaling; Glycemic control

Manuscript Timeline: Received: 02 November 2024; Revised: 10 February 2025; Accepted: 22 February 2025; Published: 05 March 2025

Citation: Patel, G. H., & Van Der Merwe, I. J. (2025). Mechanisms of Insulin Resistance in Gestational Diabetes Mellitus and Therapeutic Implications for Fetal Outcomes. International Journal of Medical Advances and Discoveries, 16(3), 9–16.

Subscribe to read the full article: https://9journals.org/subscribe-to-read